KFDA to strengthen safeguards for children taking paroxetine

Published: 2007-03-08 06:56:00

Updated: 2007-03-08 06:56:00

The Korea Food and Drug Administration (KFDA) said on March 5 that it will closely monitor the possibility of an increased risk of suicidal thoughts and behavior (suicidality) in children and adolescents being treated with an antidepressant paroxetine.

Paroxetine (or paroxetine hydrochloride) is a selective serotonin reuptake inhibitor (SSRI) antidepressant. It was released in 1992 by GlaxoS...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.